UP!

LEG $18.96

LEG target price
18.96
0
41

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2022 2023-02-06 Future report Set alerts
Q3 2022 2022-10-31 0.52 0.52
Q2 2022 2022-08-01 0.70 0.70
Q1 2022 2022-05-02 0.66 0.66
Q4 2021 2022-02-07 0.77 0.77
Q3 2021 2021-11-01 0.71 0.71
Q2 2021 2021-08-02 0.66 0.66
Q1 2021 2021-05-03 0.64 0.64
Q4 2020 2021-02-08 0.76 0.76
Q3 2020 2020-11-02 0.80 0.80

Ratings

2015-09-11 Upgrade JPMorgan Chase & Co. Neutral to Overweight
2015-08-31 Upgrade Raymond James Market Perform to Outperform $48.00
2015-08-31 Upgrade Raymond James Financial Inc. Market Perform to Outperform $48.00
2015-01-20 Downgrade Monness Crespi & Hardt Buy to Neutral $40.00 to $45.00
2014-11-12 Downgrade Raymond James Outperform to Market Perform $40.00
2014-10-24 Reiterated Rating Monness Crespi & Hardt Buy $37.00 to $40.00
2014-09-22 Upgrade Raymond James Market Perform to Outperform $38.00
2014-07-07 Boost Price Target Monness Crespi & Hardt Buy $35.00 to $37.00
2014-04-23 Boost Price Target Haywood Securities $2.00 to $11.00
2014-01-21 Upgrade Monness Crespi & Hardt Neutral to Buy $35.00
2014-01-06 Upgrade Ned Davis Research Neutral to Buy
2013-11-18 Upgrade Ned Davis Research Neutral to Buy
2013-04-19 Downgrade Monness Crespi & Hardt Buy to Neutral
2012-02-07 Upgrade Hilliard Lyons Neutral to Long-term Buy $28
2010-10-25 Downgrade Stifel Nicolaus Buy to Hold
2009-04-23 Downgrade Hilliard Lyons Buy to Long-term Buy $15 to $16
2009-02-04 Reiterated Hilliard Lyons Buy $20 to $15
2008-12-17 Reiterated Hilliard Lyons Buy $23 to $20
2008-08-25 Upgrade Stifel Nicolaus Hold to Buy $25
2007-12-04 Downgrade Morgan Keegan Mkt Perform to Underperform
2007-10-15 Initiated Hilliard Lyons Buy $25
2007-01-29 Downgrade Longbow Buy to Neutral
2015-09-11 Upgrade JPMorgan Chase & Co. Neutral to Overweight
2015-08-31 Upgrade Raymond James Market Perform to Outperform $48.00
2015-08-31 Upgrade Raymond James Financial Inc. Market Perform to Outperform $48.00
2015-01-20 Downgrade Monness Crespi & Hardt Buy to Neutral $40.00 to $45.00
2014-11-12 Downgrade Raymond James Outperform to Market Perform $40.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
HAFFNER DAVID S Chief Executive Officer 0.92%  (1263073) BMS / LEG /
GLASSMAN KARL G President & COO 0.26%  (352754) LEG / REMY /
PARK DENNIS S Senior Vice President 0.20%  (277881) LEG /
CRUSA JACK D Senior Vice President 0.15%  (204211) LEG /
FISHER RICHARD T 0.11%  (144715) LEG /
WEIL WILLIAM S Vice Pres - Corp Controller 0.10%  (141103) LEG /
FLANIGAN MATTHEW C Executive Vice President - CFO 0.09%  (119927) JKHY / LEG /
DAVIS PERRY E Senior Vice President 0.08%  (110117) LEG /
DOLLOFF J MITCHELL Senior Vice President 0.07%  (94617) LEG /
DOWNES JOSEPH D JR Senior Vice President 0.06%  (76313) LEG /
DeSonier David M SVP-Strategy&InvestorRelations 0.05%  (68784) LEG /
WOOD PHOEBE A 0.05%  (64165) CCE / IVZ / LEG / PPL / PXD /
Iorio Russell J VP - Mergers & Acquisitions 0.04%  (61342) LEG /
ODOM JUDY C 0.04%  (55053) HHS / LEG / SABR /
CLARK RALPH W 0.03%  (46247) LEG /
ENLOE ROBERT TED III 0.03%  (36854) LEG / LYV / SLAB /
Brunner Robert E 0.03%  (36465) LEG / LNN / NNBR /
MCCLANATHAN JOSEPH W 0.02%  (32933) LEG /
Douglas Scott S SVP - General Counsel 0.02%  (32667) LEG /
Moore John G. SVP - Chief Legal & HR Officer 0.02%  (28811) LEG /
FERNANDEZ MANUEL A 0.02%  (21296) BC / FLO / LEG / SYY / TIBX / TIME /
CULP ROBERT G III 0.01%  (18123) CFI / LEG / ODFL / STLY /
TRENT TAMMY M VP - Chief Accounting Officer 0.01%  (12747) LEG /